- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07268196
Impact of Liver Transplantation on Sexual Life and Function
December 24, 2025 updated by: Institute of Liver and Biliary Sciences, India
Liver Transplantation (LT) is a lifesaving intervention with around 90% of recipients currently surviving the first postoperative year and subsequent life expectancy now exceeding 20 years.
After the post-operative recovery period, however, LT recipients become more and more confronted with the challenges of re-engagement with life after transplantation, a need to reach a new stability, reestablish function in everyday life, reconnect with valued roles, regain independence, and resume work Sexual function is a very important parameter in the evaluation of Quality of Life (QoL), as it has been shown that sexual dysfunction in transplant patients is associated with increased depression and decreased QoL.
There are several studies in the relevant literature supporting the recovery of sexual function in patients after liver transplantation.
It has been found that recovery was observed in erectile dysfunction in male patients 6 months after liver transplantation.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Liver Transplantation (LT) is a lifesaving intervention with around 90% of recipients currently surviving the first postoperative year and subsequent life expectancy now exceeding 20 years.
After the post-operative recovery period, however, LT recipients become more and more confronted with the challenges of re-engagement with life after transplantation, a need to reach a new stability, reestablish function in everyday life, reconnect with valued roles, regain independence, and resume work Sexual function is a very important parameter in the evaluation of Quality of Life (QoL), as it has been shown that sexual dysfunction in transplant patients is associated with increased depression and decreased QoL.
There are several studies in the relevant literature supporting the recovery of sexual function in patients after liver transplantation.
It has been found that recovery was observed in erectile dysfunction in male patients 6 months after LT
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dr. Rajagopalan G, DNB
- Phone Number: 8220408324
- Email: prash1108@gmail.com
Study Locations
-
-
National Capital Territory of Delhi
-
New Delhi, National Capital Territory of Delhi, India, 110070
- Recruiting
- ILBS
-
Contact:
- Dr. Rajagopalan G, DNB
- Phone Number: 8220408324
- Email: prash1108@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Chronic Liver Disease patients awaiting elective transplantation and post liver transplant patients.
Description
Inclusion Criteria:
- Married male Patients.
- Decompensated Chronic Liver Disease awaiting elective liver transplantation.
- Post Liver Transplant patients with stable graft function.
Exclusion Criteria:
- Negative consent.
- Patients with ongoing medical and surgical issues (biliary complications, graft complication etc.).
- Acute on Chronic Liver Failure and Acute Liver Failure patients.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Chronic liver Disease
Chronic Liver disease patients undergoing elective liver transplantation
|
This is an Observational Study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of sexual function by questionnaire method
Time Frame: pre transplant, 3,6,12 months
|
Arizona Sexual Experience Scale (ASEX) scores for sexual dysfunction, ASEX scores are 5 point questionnaire with scores given for each question from 1-6.
Total scores More than or equal to 19 indicate sexual dysfunction (higher the scores greater the sexual dysfunction).
|
pre transplant, 3,6,12 months
|
|
Evaluation of erectile dysfunction using questionnaire method
Time Frame: pre transplant, 3,6,12 months
|
International Index for Erectile Function - 5 (IIEF-5) scores for erectile dysfunction IIEF 5 scores are also a 5 point questionnaire with score ranging 0-6 for each question.
Total scores less than 15 indicate mild to moderate erectile dusfunction and scores less than 11 indicate moderate erectile dysfunction (lower the scores higher the erectile dysfunction)
|
pre transplant, 3,6,12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation between testosterone and Meld Na scores
Time Frame: pre transplant, 3,6,12 months
|
Testosterone measured in ng/ml.
Less than 2.84 ng/ml is considered as hypogonadism
|
pre transplant, 3,6,12 months
|
|
Sarcopenia implication in recovery of sexual function.
Time Frame: pre transplant, 3,6,12 months
|
Sarcopenia measured by third lumbar vertebra Skeletal muscle index.
Values less than 52 indicates sarcopenia
|
pre transplant, 3,6,12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Prof. Dr. Viniyendra Pamecha, MS FEBS, ILBS
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 7, 2025
Primary Completion (Estimated)
October 23, 2026
Study Completion (Estimated)
October 23, 2026
Study Registration Dates
First Submitted
November 22, 2025
First Submitted That Met QC Criteria
December 3, 2025
First Posted (Estimated)
December 5, 2025
Study Record Updates
Last Update Posted (Actual)
December 31, 2025
Last Update Submitted That Met QC Criteria
December 24, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IEC/2024/110/MA03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Liver Disease and Cirrhosis
-
Jorge L PooCompletedCirrhosis, Liver | Liver Fibrosis | Chronic Liver Disease
-
Massachusetts General HospitalRecruitingCirrhosis | Cirrhosis, Liver | End Stage Liver DIsease | Liver Disease Chronic | Advanced CirrhosisUnited States
-
Cairo UniversityNational Liver Institute, EgyptCompletedCirrhosis and Chronic Liver DiseaseEgypt
-
University of NottinghamMediplus Ltd UK; Enteric healthcare technology Co-operativeCompletedAscites Hepatic | Cirrhosis and Chronic Liver DiseaseUnited Kingdom
-
Hospital Sao RafaelMinistry of Health, Brazil; Ministry of Science and Technology, BrazilUnknownHepatic Cirrhosis | Chronic HepatitisBrazil
-
Indiana UniversityRecruitingCirrhosis, Liver | Chronic Liver DiseaseUnited States
-
Sohag UniversityCompleted
-
Postgraduate Institute of Medical Education and...CompletedAcute-On-Chronic Liver Failure | Cirrhosis, LiverIndia
-
University of Medicine and Pharmacy CraiovaUniversity of Medicine and Pharmacy "Victor Babes" TimisoaraUnknownCirrhosis | Chronic Liver DiseaseRomania
-
University of Medicine and Pharmacy CraiovaUniversity of Medicine and Pharmacy "Victor Babes" TimisoaraUnknown
Clinical Trials on No Treatment
-
HealthpointCompletedVenous Leg Ulcer (VLU)Germany, Poland, Belgium, Hungary, Czechia
-
HealthpointCompleted
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
University Hospital, GrenobleUnknownObstructive Sleep Apnea Syndrome | HypertensionFrance
-
Anna Alessandri BonettiCompletedPain | Sleep Apnea Syndromes | Sleep Apnea, Obstructive | Sleep Apnea | Temporomandibular Disorder | Pain, FaceItaly
-
Surf TherapeuticsRecruitingRheumatoid Arthritis (RAUnited States
-
Ottawa Heart Institute Research CorporationActive, not recruitingMitral RegurgitationCanada
-
University of PaviaCompletedClinical Efficacy of Biomimetic Hydroxyapatite in the Treatment of Molar Incisor Hypomineralization.Molar Incisor HypomineralizationItaly
-
University of Texas Southwestern Medical CenterCompletedDepression | Other Diagnoses, Comorbidities, and ComplicationsUnited States
-
ShireCompletedHunter SyndromeUnited States, United Kingdom